Form D · Biotechnology
PATHWAY MEDICAL TECHNOLOGIES INC
Kirkland, WA · CIK 0001076719
Offering snapshot reported Sep 17, 2010 · SEC filing
- Reported sold
- $9.93M Offering amount: $20M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 17, 2010 | Initial | $9,933,800 | No comparison | 13 | SEC filing |
| Mar 10, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 20, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $100K (estimated)
- Form D file number
- 021-147928
Source: Form D, filed Sep 17, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Auth | Director |
| Michael Behlke | Executive |
| Paul Buckman | Director, Executive, Promoter |
| J. Daniel Cole | Director |
| Daniel Galles | Director |
| Avi Molcho | Director |
| Martien Van Osch | Director |
| Ted Wulfman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10801 120 Th Ave. Ne
Kirkland, WA, 98033
Kirkland, WA, 98033